UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 25, 2006
BIOMET, INC.
(Exact name of registrant as specified in its charter)
Indiana 0-12515 35-1418342
------------------------------- ------------- --------------------
(State or other jurisdiction of (Commission (IRS Employer
incorporation) File Number) Identification No.)
56 East Bell Drive
Warsaw, Indiana 46582
---------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (574) 267-6639
Not Applicable
------------------------------------------------------------------------------
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of
the following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 5.02. Departure of Directors or Principal Officers; Election of
Directors; Appointment of Principal Officers.
On March 27, 2006, Biomet, Inc. (the "Company") announced the appointment of
Daniel P. Hann as interim President and Chief Executive Officer of the
Company. He succeeds Dane A. Miller, Ph.D., who has decided to retire from
day-to-day operations as President and Chief Executive Officer, but will
remain on the Board and continue to serve as a consultant to the Company. Brad
Tandy will succeed Mr. Hann as interim General Counsel and Secretary.
A copy of the Company's press release announcing the foregoing is filed as
Exhibit 99.1 hereto and is incorporated herein by reference.
Mr. Hann, 50, served as Senior Vice President, General Counsel and Secretary
and has been an officer and director since joining the Company in 1989. He is
a member of the NASDAQ Listing and Hearing Review Council of The NASDAQ
Stock Market, Inc. He received his B.S. from California State University,
Fullerton, his M.S. from the University of Illinois, and his J.D. from Indiana
University.
Mr. Hann does not have an employment agreement with the Company.
Item 9.01. Financial Statements and Exhibits.
Exhibit 99.1 Press Release issued March 27, 2006
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
BIOMET, INC.
Date: March 30, 2006 By: /s/ Daniel P. Hann
------------------------------
Name: Daniel P. Hann
Title: Interim President and
Chief Executive Officer
Exhibit Index
Exhibit 99.1 Press Release issued March 27, 2006